Telecom Healthcare Sector

SCYNEXIS

Market Cap: US$30.8m

A biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States.

Tissue Regenix Group

Market Cap: UK£23.2m

A medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally.

Burning Rock Biotech

Market Cap: US$30.7m

Primarily develops and sells cancer therapy selection tests in the People's Republic of China.

Abingdon Health

Market Cap: UK£22.9m

Operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally.

Revium Rx

Market Cap: US$30.4m

A pre-clinical stage biopharmaceutical company, develops nano-liposomal particles (NLP) based pharmaceutical candidates.

IDT Australia

Market Cap: AU$47.3m

Engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States.

Angion Biomedica

Market Cap: US$30.1m

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for chronic and progressive fibrotic diseases in the United States.

Quantum BioPharma

Market Cap: CA$42.0m

Operates as a biopharmaceutical company.

CASI Pharmaceuticals

Market Cap: US$30.1m

A biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China, the United States, and internationally.

MiNK Therapeutics

Market Cap: US$29.9m

A clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases.

Kezar Life Sciences

Market Cap: US$29.7m

A clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States.

Vitura Health

Market Cap: AU$46.4m

Engages in the sale and distribution of medicinal cannabis products in Australia.

Ayr Wellness

Market Cap: CA$41.5m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.

Cleo Diagnostics

Market Cap: AU$46.3m

A medical diagnostics and devices company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia.

Ocumetics Technology

Market Cap: CA$41.3m

Engages in research, development, production, and sale of vision enhancement products in Canada.

Enzo Biochem

Market Cap: US$29.2m

A life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.

IntelGenx Technologies

Market Cap: US$29.2m

A drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market.

Cadrenal Therapeutics

Market Cap: US$29.1m

Operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions.

Perimeter Medical Imaging AI

Market Cap: CA$40.7m

A medical technology company, provides advanced imaging tools that address unmet medical needs.

Cynata Therapeutics

Market Cap: AU$45.2m

Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.

Decibel Cannabis

Market Cap: CA$40.4m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Light AI

Market Cap: CA$40.4m

A healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.

Femasys

Market Cap: US$28.8m

A biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally.

Sareum Holdings

Market Cap: UK£21.5m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

Cannabist Company Holdings

Market Cap: US$28.3m

The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally.

Sona Nanotech

Market Cap: CA$39.4m

Operates as a nanotechnology life sciences company.

PolyPid

Market Cap: US$28.0m

A clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs.

Advanced Biomed

Market Cap: US$27.5m

An investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan.

DarioHealth

Market Cap: US$27.4m

Operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand.

Growth Stalk Holdings

Market Cap: US$27.4m

Engages in the sowing of the seeds for cultivation and selling of cannabis.

CalciMedica

Market Cap: US$27.0m

A clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage.

OnKure Therapeutics

Market Cap: US$26.9m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers.

INOVIQ

Market Cap: AU$41.9m

Engages in the developing and commercializing of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States.

MTL Cannabis

Market Cap: CA$37.4m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

MediPharm Labs

Market Cap: CA$37.4m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

Harvard Apparatus Regenerative Technology

Market Cap: US$26.4m

A clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects.